[1] |
Del Buono, M.G.; Moroni, F.; Montone, R.A.; Azzalini, L.; Sanna, T.; Abbate, A. Ischemic cardiomyopathy and heart failure after acute myocardial infarction. Curr. Cardiol. Rep. 2022, 24, 1505–1515.
|
[2] |
Napoli, C.; Bontempo, P.; Palmieri, V.; Coscioni, E.; Maiello, C.; Donatelli, F.; Benincasa, G. Epigenetic therapies for heart failure: current insights and future potential. Vasc. Health Risk Manag. 2021, 17, 247–254.
|
[3] |
Zhou, M.G.; Wang, H.D.; Zeng, X.Y.; Yin, P.; Zhu, J.; Chen, W.Q.; Li, X.H.; Wang, L.J.; Wang, L.M.; Liu, Y.N.; Liu, J.M.; Zhang, M.; Qi, J.L.; Yu, S.C.; Afshin, A.; Gakidou, E.; Glenn, S.; Krish, V.S.; Miller-Petrie, M.K.; Mountjoy-Venning, W.C.; Liang, X.F. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019, 394, 1145–1158.
|
[4] |
Zhao, Z.; Jin, J.; Yu, R. Clinical Characteristics of Acute Decompensated Heart Failure in hospitalized Senile Patients. Chin. J. Integr. Med. Cardio-Cerebrovasc. Dis. 2021, 19, 113–115.
|
[5] |
O’Gara, P.T.; Kushner, F.G.; Ascheim, D.D.; Casey Jr, D.E.; Chung, M.K.; de Lemos, J.A.; Zhao, D.X. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiolo. 2013, 61, 485–510.
|
[6] |
Ni, J.D.; Li, X.; Liu, M.; Zhu, H.S.; Ling, M.R. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack (2014 AHA/ASA edition). Chin. J. Clin. Neurosciences. 2015, 23, 168–174.
|
[7] |
Ibanez, B.; James, S.; Agewall, S.; Antunes, M.J.; Bucciarelli-Ducci, C.; Bueno, H.; Caforio, A.L.P.; Crea, F.; Goudevenos, J.A.; Halvorsen, S.; Hindricks, G.; Kastrati, A.; Lenzen, M.J.; Prescott, E.; Roffi, M.; Valgimigli, M.; Varenhorst, C.; Vranckx, P.; Widimský, P.; Scientific Document Group, E.S.C. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2018, 39, 119–177.
|
[8] |
Yi, R.; Dong, L.; Bian, Y.; Wang, L.J.; Pharmaceutical care of rivaroxaban in treatment of left ventricle mural thrombosis after PCI in one acute myocardial infarction patient. Chin. J. New Drugs Clin. Remedies. 2022, 41, 57–59.
|
[9] |
Zhu, Y.X.; Sheng, F.Q.; Chen, X.J.; Guo, J.; Lin, L.L.; Rivaroxaban in a case of combined left ventricular appendage thrombosis after stenting for acute myocardial infarction complicated by cerebral hemorrhage. J. Clin. Int. Med. 2021, 38, 275–276.
|
[10] |
Guide to the rational use of medication in coronary heart disease (2nd edition). Chin. J. Front. Med. Sci. 2018, 10, 1–130.
|
[11] |
Liu, X.; Chen Y. X.; Zeng, R.; Zheng, Y. H.; Liu, B. Clinical effectiveness of rivaroxaban versus warfarin in the treatment of lower limb deep vein thrombosis. Chin. J. General. Surg. 2017, 32, 512–515.
|
[12] |
Collins, A.J.; Pitt, B.; Reaven, N.; Funk, S.; McGaughey, K.; Wilson, D.; Bushinsky, D.A. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am. J. Nephrol. 2017, 46, 213–221.
|
[13] |
Cooper, L.B.; Benson, L.; Mentz, R.; Savarese, G.; DeVore, A.; Carrero, J.J.; Dahlstrom, U.; Anker, S.; Lainscak, M.; Hernandez, A.; Pitt, B.; Lund, L. Association between serum potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish heart failure registry. J. Am. Coll. Cardiol. 2017, 69, 678.
|
[14] |
Expert consensus on ion management in Chinese heart failure patients. Chin. J. Heart Failure. Cardiomyopathy. 2020, 4, 16–31.
|
[15] |
Yang, Y. A case of liver damage and creatine kinase elevation due to the combination of atorvastatin and voriconazole. Chin. J. Clin. Rational. Drug Use. 2020, 13, 21, 24.
|
[16] |
Du, Y.A.; Wang, T.A.; Jiang, N.; Ren, R.T.; Zhao, D.L.; Li, C.; Fu, F.H. Protective effect of sodium aescinate on lung injury induced by methyl parathion. Hum. Exp. Toxicol. 2011, 30, 1584–1591.
|
[17] |
Cao, D.; Wang, Z. B.; Cheng, J. Analysis of the outpatient prescriptions of potential metabolic interactions between amiodarone and statins. Pract. Pharm. Clin. Remedies. 2021, 24, 738–741.
|
[18] |
Deng, F.; Tuomi, S.K.; Neuvonen, M.; Hirvensalo, P.; Kulju, S.; Wenzel, C.; Oswald, S.; Filppula, A.M.; Niemi, M. Comparative hepatic and intestinal efflux transport of statins. Drug Metab. Dispos. 2021, 49, 750–759.
|